{
    "root": "b7562df3-2e18-4454-83e9-e0ebaccf25a9",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Glatiramer Acetate",
    "value": "20250207",
    "ingredients": [
        {
            "name": "GLATIRAMER ACETATE",
            "code": "5M691HL4BO"
        },
        {
            "name": "MANNITOL",
            "code": "3OWL53L36A"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "indications": "glatiramer acetate injection indicated treatment relapsing forms multiple sclerosis ( multiple sclerosis ) , include clinically isolated syndrome , relapsing-remitting disease , active secondary progressive disease , adults .",
    "contraindications": "• subcutaneous injection ; doses interchangeable ( 2.1 ) • glatiramer acetate injection 20 mg/ml per day ( 2.1 ) • , allow solution warm room temperature ( 2.2 )",
    "warningsAndPrecautions": "glatiramer acetate injection clear , colorless slightly yellow , sterile , nonpyrogenic solution 1 ml single-dose , prefilled syringe fixed ½ inch 29 gauge needle supplied : •20 mg/ml single-dose , prefilled syringe light blue plunger , individual blister packages supplied 30-count cartons ( ndc 0378-6960-93 ) . glatiramer acetate products administered optional compatible autoinjector . compatible autoinjectors supplied separately available , availability compatible autoinjectors may change time [ ( 5.7 ) patient counseling information ( 17 ) ] . store glatiramer acetate injection refrigerated 2° 8°c ( 36° 46°f ) . needed , patient may store glatiramer acetate injection room temperature , 15° 30°c ( 59° 86°f ) , one month , refrigeration preferred . avoid exposure higher temperatures intense light . freeze glatiramer acetate injection . glatiramer acetate syringe freezes , discarded . pharmacist : dispense medication guide prescription .",
    "adverseReactions": "glatiramer acetate injection contraindicated patients known hypersensitivity glatiramer acetate mannitol . included anaphylaxis [ ( 5.1 ) ] .",
    "indications_original": "Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.",
    "contraindications_original": "• For subcutaneous injection only; doses are not interchangeable ( 2.1 ) • Glatiramer acetate injection 20 mg/mL per day ( 2.1 ) • Before use, allow the solution to warm to room temperature ( 2.2 )",
    "warningsAndPrecautions_original": "Glatiramer Acetate Injection is a clear, colorless to slightly yellow, sterile, nonpyrogenic solution in a 1 mL single-dose, prefilled syringe with fixed ½ inch 29 gauge needle supplied as: \n                  \n                     \n                        •20 mg/mL in a single-dose, prefilled syringe with a light blue plunger, in individual blister packages supplied in 30-count cartons (NDC 0378-6960-93). \n                  \n                  Some glatiramer acetate products can be administered by an optional compatible autoinjector. Compatible autoinjectors are supplied separately if available, but the availability of compatible autoinjectors may change with time [see \n                     \n                        Warnings and Precautions (5.7)\n                     \n                      and Patient Counseling Information (17)].\n                  Store glatiramer acetate injection refrigerated at 2° to 8°C (36° to 46°F). If needed, the patient may store glatiramer acetate injection at room temperature, 15° to 30°C (59° to 86°F), for up to one month, but refrigeration is preferred. Avoid exposure to higher temperatures or intense light. Do not freeze glatiramer acetate injection. If a glatiramer acetate syringe freezes, it should be discarded.\n                  \n                     PHARMACIST: Dispense a Medication Guide with each prescription.",
    "adverseReactions_original": "Glatiramer acetate injection is contraindicated in patients with known hypersensitivity to glatiramer acetate or mannitol. Reactions have included anaphylaxis [see Warnings and Precautions (5.1)]\n                     ."
}